Medical News

RSS

Novo Nordisk completes patient enrollment in A1chieve study for type 2 diabetes management

Today, Novo Nordisk announced the landmark recruitment of the 60,000th patient in the A1chieve(R) study - an observational study designed to investigate the effects of modern insulins in the management of type 2 diabetes.

From Novo Nordisk 20 Jul 2010

Scientists find major shortcomings in assessing CVD risk in HIV patients

At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus, two international meetings of HIV/AIDS scientists and patient advocates find major shortcomings in the design and analysis of studies used to assess cardiovascular disease risk in people with HIV with significant implications for improving medical care.

20 Jul 2010

MDMA (Ecstasy) holds promise for chronic treatment-resistant PTSD

MDMA (-3,4-methylenedioxymethamphetamine, also known as Ecstasy), may one day offer hope for individuals with posttraumatic stress disorder (PTSD), even people for whom other treatments have failed. Clinical trial results out today in the Journal of Psychopharmacology, published by SAGE, suggests that MDMA can be administered to subjects with PTSD without evidence of harm and could offer sufferers a vital window with reduced fear responses where psychotherapy can take effect.

20 Jul 2010

Case Western Reserve awarded $0.5M for study of breast cancer in older women

Cynthia Owusu, MD, associate professor at Case Western Reserve University and geriatric-oncologist at University Hospitals Case Medical Center, the School's primary affiliate, has received nearly $500,000 from Susan G. Komen For the Cure to fund a novel three-year study aimed at improving outcomes for older women with newly-diagnosed breast cancer.

20 Jul 2010

Ratio secures equity financing

Ratio, Inc. has secured equity financing from regional angel investors and angel networks. The groups participating in the round include Wisconsin Investment Partners, The Golden Angels Network, Stateline Angels, and Central Illinois Angels. The company is keeping the round of financing open for 120 days and actively pursuing further investment.

20 Jul 2010

LCA opens registration for next Team Lung Love event

Today, Lung Cancer Alliance (LCA) opened registration for the next Team Lung Love event. Members of Team Lung Love can participate in the Philadelphia Marathon, Half-Marathon and 8K this November. Team Lung Love is LCA's endurance sports training program is focused exclusively on raising awareness and support for lung cancer.

20 Jul 2010

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

A Phase 3 open-label study, recently published online by Pain Practice, has compared tapentadol extended release tablets, an investigational pain medication, to an existing prescription pain medication, oxycodone controlled release tablets.

20 Jul 2010

CytRx updates on progress in clinical development of bafetinib in three oncology indications

CytRx Corporation, a biopharmaceutical company specializing in oncology, announces progress with its clinical program to evaluate the preliminary efficacy and safety of its drug candidate bafetinib in three oncology indications. The Company has enrolled its first patient in a Phase 2 proof-of-concept trial in patients with high-risk B-cell chronic lymphocytic leukemia (B-CLL), is reporting rapid advancement toward the initiation of a Phase 2 proof-of-concept trial in advanced prostate cancer, and is on track to begin clinical evaluation later this year in glioblastoma multiforme, a common and aggressive type of primary brain tumor.

20 Jul 2010

Parkinson's medication produces serious side effects in the form of involuntary, jerky movements: Research

One in every 100 elderly people suffers from Parkinson's disease, a disease of the nervous system with symptoms including stiffness and shaking. The standard medication used to treat Parkinson's is Levodopa, a drug that initially has major benefits but can later also produce serious side effects in the form of involuntary, jerky movements. A research group at Lund University has now found a way to study what it is in the brain that causes these side effects.

20 Jul 2010

Pfizer suspends chronic low back pain, diabetic peripheral neuropathy studies in tanezumab clinical program

Pfizer Inc. today announced, at the request of the U.S. Food and Drug Administration (FDA), the suspension of the chronic low back pain and painful diabetic peripheral neuropathy studies in the clinical program for the investigational compound tanezumab. Investigation of the compound continues in some areas of high unmet medical need, including cancer pain.

20 Jul 2010

AHF calls upon US to honor commitment to PEPFAR

Doctors and AIDS advocates from AIDS Healthcare Foundation (AHF), which provides AIDS medical care to more than 138,000 individuals in 23 countries worldwide, will host a press conference at the International AIDS Conference in Vienna on Monday, July 19th at 12 noon (Media Center, Room PCR #3) to reiterate their call on the United States to honor the its landmark commitment to PEPFAR (the President's Emergency Plan for AIDS Relief), the successful US global AIDS program.

20 Jul 2010

WHO advises earlier treatment for people with HIV

An estimated 5.2 million people were receiving life-saving HIV treatment at the end of 2009, according to the latest update from the WHO. WHO estimates that 1.2 million people started treatment in 2009, bringing the total number of people receiving treatment to 5.2 million, compared to 4 million at the end of 2008.

20 Jul 2010

LRGHealthcare deploys Aruba's application-aware 802.11n Wi-Fi networks for clinical mobility needs

Aruba Networks, Inc., a global leader in distributed enterprise network solutions, today announced that LRGHealthcare (LRGH), a healthcare charitable trust based in New Hampshire, has deployed Aruba's application-aware 802.11n Wi-Fi networks to address growing clinical mobility needs throughout the Lakes Region General Hospital, Franklin Regional Hospital, and associated clinics in the cities of Lanconia, Franklin, Gilford, and Meredith.

20 Jul 2010

Cellectis bioresearch introduces new technology to develop cell-based assays for HTS studies

Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable cell lines compatible with high throughput screening (HTS).The study demonstrated Cellectis bioresearch's technology to be faster, more reliable and efficient in deriving cell-based assays for HTS studies than classical methods.

20 Jul 2010

BC-CfE study suggests HAART may prevent transmission, spread of HIV

The BC Centre of Excellence in HIV/AIDS published an important study today in the globally respected Lancet medical journal. The study strongly reinforces the view that the benefits of highly active antiretroviral therapy extend beyond treatment of the virus to significantly preventing the transmission and spread of HIV.

20 Jul 2010

Univfy, Stanford scientists develop first validated prognostic test for predicting IVF live birth outcomes

Univfy, a pioneer in the development of personalized in vitro fertilization (IVF) prognostic tools, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by its founding scientific team and clinical collaborators from Stanford University.

20 Jul 2010

Cash rewards help combat STIs in rural Africa, study finds

Giving out cash can be an effective tool in combating sexually transmitted infections in rural Africa, according to a new study conducted jointly by researchers at the University of California, Berkeley, the Development Research Group at the World Bank and the Ifakara Health Institute in Tanzania.

20 Jul 2010

Combined technologies offer promise for detecting colon cancer in women

A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.

20 Jul 2010

Responding to access-to-care challenges: Ideas from a rural doctor, a Washington, D.C. hospital

Evansville (Ind.) Courier & Press reports on the struggles rural physicians face in providing care by focusing on Dr. Lloyd "Pat" McGinnis, a family medicine and geriatrics specialist who was "one of only five doctors in Spencer County, a rural area of Southwestern Indiana. … Doctors throughout the country are struggling with the same issues of providing quality care to patients with limited incomes in an environment of uncertainly as major provisions of the Patient Protection and Affordable Care Act are phased in over the next five years.

20 Jul 2010

Vertos Medical announces 12-week data from MiDAS I clinical study for lumbar spinal stenosis

Medical device company Vertos Medical Inc. has announced the unveiling of 12-week clinical data from its prospective, 75-patient MiDAS I (mild Decompression Alternative to open Surgery) study that further validate the safety and efficacy of mild for the treatment of lumbar spinal stenosis (LSS). Consistent with the positive six-week study results released in March and May, the new MiDAS I data demonstrate that mild patients continued to experience statistically significant improvement in pain, physical function and mobility 12 weeks following treatment.

20 Jul 2010

Medical News

Novo Nordisk completes patient enrollment in A1chieve study for type 2 diabetes management

Scientists find major shortcomings in assessing CVD risk in HIV patients

MDMA (Ecstasy) holds promise for chronic treatment-resistant PTSD

Case Western Reserve awarded $0.5M for study of breast cancer in older women

Ratio secures equity financing

LCA opens registration for next Team Lung Love event

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

CytRx updates on progress in clinical development of bafetinib in three oncology indications

Parkinson's medication produces serious side effects in the form of involuntary, jerky movements: Research

Pfizer suspends chronic low back pain, diabetic peripheral neuropathy studies in tanezumab clinical program

AHF calls upon US to honor commitment to PEPFAR

WHO advises earlier treatment for people with HIV

LRGHealthcare deploys Aruba's application-aware 802.11n Wi-Fi networks for clinical mobility needs

Cellectis bioresearch introduces new technology to develop cell-based assays for HTS studies

BC-CfE study suggests HAART may prevent transmission, spread of HIV

Univfy, Stanford scientists develop first validated prognostic test for predicting IVF live birth outcomes

Cash rewards help combat STIs in rural Africa, study finds

Combined technologies offer promise for detecting colon cancer in women

Responding to access-to-care challenges: Ideas from a rural doctor, a Washington, D.C. hospital

Vertos Medical announces 12-week data from MiDAS I clinical study for lumbar spinal stenosis

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News